Gilead hit with FDA clinical hold for batch of HIV trials
Pharmaceutical Technology
JUNE 11, 2025
Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gilead said it is “committed to working with regulatory authorities to resolve the issues underlying the clinical hold” Credit: Melnikov Dmitriy via Shutterstock. Gilead is considered the leading big pharma in HIV treatments.
Let's personalize your content